Lexicon Pharmaceuticals, Inc.
LXRX
$1.62
$0.010.62%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 96.23M | 115.95M | 139.01M | 194.84M | 237.96M |
| Total Receivables | 2.38M | 2.33M | 2.18M | 47.45M | 3.47M |
| Inventory | 281.00K | 158.00K | 168.00K | 201.00K | 231.00K |
| Prepaid Expenses | 3.00M | 4.09M | 3.73M | 3.32M | 4.53M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 101.90M | 122.53M | 145.08M | 245.81M | 246.19M |
|
|
|||||
| Total Current Assets | 101.90M | 122.53M | 145.08M | 245.81M | 246.19M |
| Net Property, Plant & Equipment | 9.18M | 9.49M | 6.59M | 6.95M | 7.32M |
| Long-term Investments | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M |
| Goodwill | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 29.37M | 29.37M | 29.37M | 368.00K | 368.00K |
| Total Assets | 184.99M | 205.93M | 225.58M | 297.67M | 298.42M |
|
|
|||||
| Total Accounts Payable | 3.08M | 3.80M | 5.90M | 10.69M | 14.80M |
| Total Accrued Expenses | 11.55M | 11.98M | 10.57M | 11.90M | 29.27M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.24M | 1.64M | 909.00K | 43.10M | 1.18M |
| Total Finance Division Other Current Liabilities | -- | 4.30M | 17.46M | 45.00M | -- |
| Total Other Current Liabilities | -- | 4.30M | 17.46M | 45.00M | -- |
| Total Current Liabilities | 20.87M | 21.72M | 34.84M | 110.69M | 45.25M |
|
|
|||||
| Total Current Liabilities | 20.87M | 21.72M | 34.84M | 110.69M | 45.25M |
| Long-Term Debt | 49.41M | 56.51M | 56.11M | 58.64M | 100.30M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 6.80M | 4.40M | 4.52M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.17M | 740.00K | 800.00K | 783.00K | 6.92M |
| Total Liabilities | 77.45M | 85.77M | 96.14M | 174.64M | 152.47M |
|
|
|||||
| Common Stock & APIC | 2.13B | 2.13B | 2.12B | 2.12B | 2.12B |
| Retained Earnings | -2.02B | -2.00B | -1.99B | -1.99B | -1.97B |
| Treasury Stock & Other | -5.16M | -5.16M | -5.20M | -5.16M | -4.50M |
| Total Common Equity | 107.54M | 120.16M | 129.44M | 123.03M | 145.95M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 107.54M | 120.16M | 129.44M | 123.03M | 145.95M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 107.54M | 120.16M | 129.44M | 123.03M | 145.95M |
|
|
|||||